Industry News
Starpharma brings its novel technology to leading cancer treatment
Starpharma (ASX:SPL) is conducting pre-clinical studies on popular chemotherapy treatment, docaetaxel, reformulated using the company’s dendrimer technology. [ + ]
BIO 2011: Kim Carr on the importance of biotechnology
Senator Kim Carr, Minister for Innovation, Industry, Science and Research, says biotechnology is central to Labor’s agenda. [ + ]
R&D Tax Credit positions Australian biotechs for Asian boom
The R&D Tax Credit will bring more research funding to Australia to capitalise on the burgeoning Asian health market, says Barry Thomas from Cook Medical. [ + ]
Life Sciences Queensland to officially launch this week
Life Sciences Queensland, a new industry association for the biotechnology sector in the sunshine state, will officially commence operations on 1 July. [ + ]
Australian biotechs front up at BIO 2011
Over 30 Australian life sciences organisations and biotechnology companies will be present at BIO 2011, which launches today. [ + ]
BIO 2011 biotech profile: Patrys, from theory to practice
Taking Patrys’ antibody technology from the lab to the clinic was no small feat. Now those hurdles have been overcome, Patrys is looking towards the future. [ + ]
BIO 2011 biotech profile: Patrys
Patrys has overcome substantial hurdles to show its innovative approach to cancer treatment using natural antibodies is ready for the big leagues. [ + ]
CSL receives official warning from FDA
The US Food and Drug Administration has issued an official warning letter to CSL listing concerns about the manufacture of influenza vaccine, Afluria. [ + ]
AusBiotech supports research exemption in patent reform Bill
AusBiotech has welcomed the research exemption from patent infringement in Australia’s intellectual property reform bill introduced into Parliament today. [ + ]
BIO 2011 biotech profile: Mesoblast’s vision from the top
Mesoblast CEO, Professor Silviu Itescu , was instrumental in cutting the historic billion-dollar deal with Cephalon. He speaks to ALS about how he did it. [ + ]
BIO 2011 biotech profile: Mesoblast
Mesoblast has been making great strides in its stem cell technology over the past several years, and it all paid off with a game changing deal cut with US pharma Cephalon late last year. [ + ]
Top-performing Australian students strive for gold
The 23 talented students chosen to represent Australia at the UNESCO-sanctioned International Science and Mathematical Olympiads have received their team blazers at a ceremony in Parliament House, Canberra.
[ + ]R&D Tax Credit will boost small biotechs
The R&D Tax Credit will give a much needed boost to small cap biotechs, says Karen Sinclair, past president of LESANZ. [ + ]
Controversial biological and gene patent Bill delayed
The Senate has issued an extension until August for the hotly debated Patent Amendment (Human Genes and Biological Materials) Bill. [ + ]
